CN105853560A - Pimaricin dermatitis ointment and preparation method thereof - Google Patents
Pimaricin dermatitis ointment and preparation method thereof Download PDFInfo
- Publication number
- CN105853560A CN105853560A CN201610361744.5A CN201610361744A CN105853560A CN 105853560 A CN105853560 A CN 105853560A CN 201610361744 A CN201610361744 A CN 201610361744A CN 105853560 A CN105853560 A CN 105853560A
- Authority
- CN
- China
- Prior art keywords
- consumption
- weight portion
- pimaricin
- preparation
- dermatitis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/04—Sulfur, selenium or tellurium; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/20—Elemental chlorine; Inorganic compounds releasing chlorine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/36—Arsenic; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/02—Medicinal preparations containing materials or reaction products thereof with undetermined constitution from inanimate materials
- A61K35/04—Tars; Bitumens; Mineral oils; Ammonium bituminosulfonate
- A61K35/06—Mineral oils, e.g. paraffinic oils or aromatic oils based on aromatic hydrocarbons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/37—Digestive system
- A61K35/413—Gall bladder; Bile
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/58—Reptiles
- A61K35/583—Snakes; Lizards, e.g. chameleons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/282—Artemisia, e.g. wormwood or sagebrush
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/35—Caprifoliaceae (Honeysuckle family)
- A61K36/355—Lonicera (honeysuckle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/51—Gentianaceae (Gentian family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/539—Scutellaria (skullcap)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/63—Oleaceae (Olive family), e.g. jasmine, lilac or ash tree
- A61K36/634—Forsythia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/74—Rubiaceae (Madder family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/756—Phellodendron, e.g. corktree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/758—Zanthoxylum, e.g. pricklyash
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation, decoction
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Botany (AREA)
- Alternative & Traditional Medicine (AREA)
- Mycology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Inorganic Chemistry (AREA)
- Nutrition Science (AREA)
- Cell Biology (AREA)
- Dermatology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Physiology (AREA)
- Biomedical Technology (AREA)
- General Chemical & Material Sciences (AREA)
- Developmental Biology & Embryology (AREA)
- Immunology (AREA)
- Virology (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a pimaricin dermatitis ointment and a preparation method thereof. The preparation method includes the steps that 1, Chinese herbs are decocted with water, decoction is filtered, and Chinese herb extraction liquor is obtained; 2, vaseline, liquid paraffin, pimaricin, metronidazole, tanshinone, sal ammoniac, realgar, sulphur, dimethyl sulfoxide and the Chinese herb extraction liquor are mixed, and the pimaricin dermatitis ointment is prepared, wherein the Chinese herbs include the herb of shady jerusalemsage, nardostachys chinensis Batal, ramulus uncariaecum uncis, licorice roots, geckos, Chinese prickly ash, fructus forsythiae, honeysuckle flowers, radix gentianae macrophyllae, radix scutellariae, cortex phellodendri and calculus bovis. The pimaricin dermatitis ointment prepared with the method is high in cure rate, short in cure period and low in relapse rate on dermatitis.
Description
Technical field
The present invention relates to dermatitis ointment, in particular it relates to a kind of pimaricin dermatitis ointment and preparation side thereof
Method.
Background technology
Dermatitis and eczema are used to refer to a kind of scytitis frequently as synonym, represent skin for chemistry system
The atopic reaction of all materials such as agent, albumen, antibacterial and fungus.The pathogenic factor of dermatitis and eczema is very
Complexity, is simply divided into intrinsic factor and extrinsic factor, therebetween difficult point of primary and secondary, it is common that be connected mutually
System, synergism;Exopathogenic factor such as chemicals, cosmetics, zootoxin, fish and shrimp, pollen, dust,
Exposure to Sunlight and scratching, endogenous cause of ill includes inherited genetic factors, Nervous and Mental Factors, the immune factor of body and metabolic factor
Deng.The impact of dermatitis and eczema is increasingly come into one's own by psychological factor, the generation of dermatitis and eczema
It is also possible to there is certain relation with diet, rule of life and environment etc..
At present, the medicine of dermatitis and eczema can be divided into Western medicine and Chinese medicine, and the drug effect of Western medicine is fast, but
Dermatitis and eczema easily recurs, the drug effect slow-motion of Chinese medicine and cause treatment cycle long, but it is low to control recurrence rate after healing.
It can thus be seen that either all there is certain defect in Western medicine or Chinese medicine.
Summary of the invention
It is an object of the invention to provide a kind of pimaricin dermatitis ointment and preparation method thereof, pass through the method
The pimaricin dermatitis ointment prepared is high to the cure rate of dermatitis, the healing cycle is short and relapse rate is low.
To achieve these goals, the invention provides the preparation method of a kind of pimaricin dermatitis ointment,
Including:
1) carry out Chinese herbal medicine in water decocting, filtering prepared extracts of Chinese herbal medicine;
2) by vaseline, liquid Paraffin, pimaricin, metronidazole, TANSHINONES, Sal Ammoniacus, Realgar,
Sulfur, dimethyl sulfoxide and extracts of Chinese herbal medicine are mixed to prepare pimaricin dermatitis ointment;
Wherein, Chinese herbal medicine contains Herba phlomidis, fragrant high, Ramulus Uncariae Cum Uncis, Radix Glycyrrhizae, Gekko Swinhonis, Pericarpium Zanthoxyli, Fructus Forsythiae, gold silver
Flower, Radix Gentianae Macrophyllae, Radix Scutellariae, Cortex Phellodendri and Calculus Bovis.
Present invention also offers a kind of pimaricin dermatitis ointment, this pimaricin dermatitis ointment is by above-mentioned
Method be prepared.
By technique scheme, the present invention is by each component in above-mentioned preparation method and each step
Synergism make that the drug effect of pimaricin dermatitis ointment prepared is fast, cure rate is high, the healing cycle is short and
Relapse rate is low, thus overcomes the respective defect of prior art Chinese medicine and western medicine, Chinese medicine, and then improves dermatitis
The therapeutic effect of eczema.
Other features and advantages of the present invention will be described in detail in detailed description of the invention part subsequently.
Detailed description of the invention
Hereinafter the detailed description of the invention of the present invention is described in detail.It should be appreciated that this place is retouched
The detailed description of the invention stated is merely to illustrate and explains the present invention, is not limited to the present invention.
The invention provides the preparation method of a kind of pimaricin dermatitis ointment, including:
1) carry out Chinese herbal medicine in water decocting, filtering prepared extracts of Chinese herbal medicine;
2) by vaseline, liquid Paraffin, pimaricin, metronidazole, TANSHINONES, Sal Ammoniacus, Realgar,
Sulfur, dimethyl sulfoxide and extracts of Chinese herbal medicine are mixed to prepare pimaricin dermatitis ointment;
Wherein, Chinese herbal medicine contains Herba phlomidis, fragrant high, Ramulus Uncariae Cum Uncis, Radix Glycyrrhizae, Gekko Swinhonis, Pericarpium Zanthoxyli, Fructus Forsythiae, gold silver
Flower, Radix Gentianae Macrophyllae, Radix Scutellariae, Cortex Phellodendri and Calculus Bovis.
Step 1 in the present invention) in, the consumption of Chinese herbal medicine can select in wide scope, but is
Improve the drug effect of pimaricin dermatitis ointment, cure rate, healing cycle and the relapse rate prepared;Preferably
Ground, relative to the Herba phlomidis of 100 weight portions, fragrant high consumption is 64-77 weight portion, and the consumption of Ramulus Uncariae Cum Uncis is
44-65 weight portion, the consumption of Radix Glycyrrhizae is 10-22 weight portion, and the consumption of Gekko Swinhonis is 55-62 weight portion, flower
The consumption of green pepper is 34-47 weight portion, and the consumption of Fructus Forsythiae is 90-105 weight portion, and the consumption of Flos Lonicerae is
60-84 weight portion, the consumption of Radix Gentianae Macrophyllae is 37-42 weight portion, and the consumption of Radix Scutellariae is 47-58 weight portion, yellow
The consumption of cypress is 33-42 weight portion, and the consumption of Calculus Bovis is 5-9 weight portion.
Step 1 in the present invention) in, the consumption of water can select in wide scope, but in order to carry
The high drug effect of pimaricin dermatitis ointment, cure rate, healing cycle and the relapse rate prepared;Preferably,
Relative to the described Herba phlomidis of 100 weight portions, the consumption of described water is 500-800 weight portion.
Step 1 in the present invention) in, the actual conditions of decoction can select in wide scope, but
In order to improve the prepared drug effect of pimaricin dermatitis ointment, cure rate, healing cycle and relapse rate;Excellent
Selection of land, decocts and at least meets following condition: decocting temperature and be 110-130 DEG C, decocting time is 3-5h.
Step 2 in the present invention) in, the consumption of each material can select in wide scope, but is
Improve the drug effect of pimaricin dermatitis ointment, cure rate, healing cycle and the relapse rate prepared;Preferably
Ground, in step 2) in, relative to the vaseline of 100 weight portions, the consumption of liquid Paraffin is 47-60
Weight portion, the consumption of pimaricin is 25-29 weight portion, and the consumption of metronidazole is 22-34 weight portion,
The consumption of TANSHINONES is 9-18 weight portion, and the consumption of Sal Ammoniacus is 3-7 weight portion, and the consumption of Realgar is 8-15
Weight portion, the consumption of sulfur is 4-8 weight portion, and the consumption of dimethyl sulfoxide is 35-47 weight portion, in
The consumption of medical herbs extracting solution is 30-37 weight portion.
In order to improve further the prepared drug effect of pimaricin dermatitis ointment, cure rate, the healing cycle and
Relapse rate, it is preferable that before decocting, the method also includes that Chinese herbal medicine is placed in water soaks.This
Sample can improve the extraction ratio of effective ingredient in Chinese herbal medicine as much as possible by the method soaked.
In above-mentioned immersion process, the actual conditions of immersion can select in wide scope, but in order to
Improve the drug effect of pimaricin dermatitis ointment, cure rate, healing cycle and the relapse rate prepared;Preferably,
Soak and at least meet following condition: soaking temperature is 25-35 DEG C, and soak time is 24-30h.
Present invention also offers a kind of pimaricin dermatitis ointment, this pimaricin dermatitis ointment is by above-mentioned
Method be prepared.
Hereinafter will be described the present invention by embodiment.
Embodiment 1
1) by Herba phlomidis, fragrant high, Ramulus Uncariae Cum Uncis, Radix Glycyrrhizae, Gekko Swinhonis, Pericarpium Zanthoxyli, Fructus Forsythiae, Flos Lonicerae, Radix Gentianae Macrophyllae,
Radix Scutellariae, Cortex Phellodendri, Calculus Bovis and water are according to 100:69:55:17:59:42:99:74:39:55:
Mixed being incorporated at 120 DEG C of the weight ratio of 38:8:700 carries out decocting 4h, filtering prepared extracts of Chinese herbal medicine;
2) at 25 DEG C, by vaseline, liquid Paraffin, pimaricin, metronidazole, TANSHINONES, Nao
Sand, Realgar, sulfur, dimethyl sulfoxide and extracts of Chinese herbal medicine are according to 100:50:27:28:14:5:
The weight ratio mixing 30min of 12:6:42:35 prepares pimaricin dermatitis ointment A1.
Embodiment 2
1) by Herba phlomidis, fragrant high, Ramulus Uncariae Cum Uncis, Radix Glycyrrhizae, Gekko Swinhonis, Pericarpium Zanthoxyli, Fructus Forsythiae, Flos Lonicerae, Radix Gentianae Macrophyllae,
Radix Scutellariae, Cortex Phellodendri, Calculus Bovis and water are according to 100:64:44:10:55:34:90:60:37:47:
Mixed being incorporated at 110 DEG C of the weight ratio of 33:5:500 carries out decocting 3h, filtering prepared extracts of Chinese herbal medicine;
2) at 25 DEG C, by vaseline, liquid Paraffin, pimaricin, metronidazole, TANSHINONES, Nao
Sand, Realgar, sulfur, dimethyl sulfoxide and extracts of Chinese herbal medicine are according to 100:47:25:22:9:3:
The weight ratio mixing 30min of 8:4:35:30 prepares pimaricin dermatitis ointment A2.
Embodiment 3
1) by Herba phlomidis, fragrant high, Ramulus Uncariae Cum Uncis, Radix Glycyrrhizae, Gekko Swinhonis, Pericarpium Zanthoxyli, Fructus Forsythiae, Flos Lonicerae, Radix Gentianae Macrophyllae,
Radix Scutellariae, Cortex Phellodendri, Calculus Bovis and water are according to 100:77:65:22:62:47:105:84:42:58:
Mixed being incorporated at 130 DEG C of the weight ratio of 42:9:800 carries out decocting 5h, filtering prepared extracts of Chinese herbal medicine;
2) at 25 DEG C, by vaseline, liquid Paraffin, pimaricin, metronidazole, TANSHINONES, Nao
Sand, Realgar, sulfur, dimethyl sulfoxide and extracts of Chinese herbal medicine are according to 100:60:29:34:18:7:
The weight ratio mixing 30min of 15:8:47:37 prepares pimaricin dermatitis ointment A3.
Embodiment 4
Carry out preparing pimaricin dermatitis ointment A4 according to the method for embodiment 1, except for the difference that, decocting
Before boiling procedure, Chinese herbal medicine is placed in the water of 30 DEG C immersion 28h.
Comparative example 1
Carry out preparing dermatitis ointment B1, except for the difference that, step 2 according to the method for embodiment 1) in do not make
Use pimaricin.
Comparative example 2
Carry out preparing dermatitis ointment B2, except for the difference that, step 2 according to the method for embodiment 1) in do not make
Use extracts of Chinese herbal medicine.
Comparative example 3
Carry out preparing dermatitis ointment B3, except for the difference that, step 2 according to the method for embodiment 1) in do not make
Use TANSHINONES.
Comparative example 4
Carry out preparing dermatitis ointment B4, except for the difference that, step 2 according to the method for embodiment 1) in do not make
Use Sal Ammoniacus.
Application examples 1
By above-mentioned dermatitis ointment, 500 example dermatitis and eczema patients are treated, statistics cure rate (%),
Cure the healing cycle in patient (my god) and relapse rate (%) after curing 1 year, concrete outcome is shown in
Table 1.
Table 1
Cure rate (%) | The healing cycle (my god) | Relapse rate (%) | |
A1 | 99.6 | 14 | 0.5 |
A2 | 99.5 | 13 | 0.4 |
A3 | 99.6 | 16 | 0.6 |
A4 | 99.8 | 14 | 0.2 |
B1 | 78.5 | 35 | 9.9 |
B2 | 81.7 | 28 | 9.5 |
B3 | 84.3 | 25 | 10.3 |
B4 | 79.8 | 31 | 11.1 |
By above-described embodiment and comparative example, the pimaricin dermatitis ointment that the present invention provides is to dermatitis
Cure rate high, cure that the cycle is short and relapse rate is low.
The preferred embodiment of the present invention described in detail above, but, the present invention is not limited to above-mentioned reality
Execute the detail in mode, in the technology concept of the present invention, can be to the technical side of the present invention
Case carries out multiple simple variant, and these simple variant belong to protection scope of the present invention.
It is further to note that each the concrete technology described in above-mentioned detailed description of the invention is special
Levy, in the case of reconcilable, can be combined by any suitable means, in order to avoid need not
The repetition wanted, various possible compound modes are illustrated by the present invention the most separately.
Additionally, combination in any can also be carried out between the various different embodiment of the present invention, as long as its
Without prejudice to the thought of the present invention, it should be considered as content disclosed in this invention equally.
Claims (8)
1. the preparation method of a pimaricin dermatitis ointment, it is characterised in that including:
1) carry out Chinese herbal medicine in water decocting, filtering prepared extracts of Chinese herbal medicine;
2) by vaseline, liquid Paraffin, pimaricin, metronidazole, TANSHINONES, Sal Ammoniacus, Realgar,
Sulfur, dimethyl sulfoxide and described extracts of Chinese herbal medicine are mixed to prepare pimaricin dermatitis ointment;
Wherein, described Chinese herbal medicine contain Herba phlomidis, fragrant high, Ramulus Uncariae Cum Uncis, Radix Glycyrrhizae, Gekko Swinhonis, Pericarpium Zanthoxyli, Fructus Forsythiae,
Flos Lonicerae, Radix Gentianae Macrophyllae, Radix Scutellariae, Cortex Phellodendri and Calculus Bovis.
Preparation method the most according to claim 1, wherein, in step 1) in, relative to 100
The described Herba phlomidis of weight portion, the high consumption of described perfume (or spice) is 64-77 weight portion, and the consumption of described Ramulus Uncariae Cum Uncis is
44-65 weight portion, the consumption of described Radix Glycyrrhizae is 10-22 weight portion, and the consumption of described Gekko Swinhonis is 55-62
Weight portion, the consumption of described Pericarpium Zanthoxyli is 34-47 weight portion, and the consumption of described Fructus Forsythiae is 90-105 weight portion,
The consumption of described Flos Lonicerae is 60-84 weight portion, and the consumption of described Radix Gentianae Macrophyllae is 37-42 weight portion, described
The consumption of Radix Scutellariae is 47-58 weight portion, and the consumption of described Cortex Phellodendri is 33-42 weight portion, described Calculus Bovis
Consumption is 5-9 weight portion.
Preparation method the most according to claim 2, wherein, described in 100 weight portions
Herba phlomidis, the consumption of described water is 500-800 weight portion.
4. according to the preparation method described in any one in claim 1-3, wherein, described decoction is extremely
Meet following condition less: decocting temperature and be 110-130 DEG C, decocting time is 3-5h.
5. according to the preparation method described in any one in claim 4, wherein, in step 2) in,
Relative to the described vaseline of 100 weight portions, the consumption of described liquid Paraffin is 47-60 weight portion, institute
The consumption stating pimaricin is 25-29 weight portion, and the consumption of described metronidazole is 22-34 weight portion, institute
The consumption stating TANSHINONES is 9-18 weight portion, and the consumption of described Sal Ammoniacus is 3-7 weight portion, described Realgar
Consumption is 8-15 weight portion, and the consumption of described sulfur is 4-8 weight portion, the consumption of described dimethyl sulfoxide
For 35-47 weight portion, the consumption of described extracts of Chinese herbal medicine is 30-37 weight portion.
6. according to the preparation method described in any one in claim 5, wherein, described decoction it
Before, described method also includes that described Chinese herbal medicine is placed in described water soaks.
7. according to the preparation method described in any one in claim 6, wherein, described immersion is at least
Meeting following condition: soaking temperature is 25-35 DEG C, soak time is 24-30h.
8. a pimaricin dermatitis ointment, it is characterised in that described pimaricin dermatitis ointment passes through
In 1-7, the method described in any one is prepared.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610361744.5A CN105853560A (en) | 2016-05-27 | 2016-05-27 | Pimaricin dermatitis ointment and preparation method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610361744.5A CN105853560A (en) | 2016-05-27 | 2016-05-27 | Pimaricin dermatitis ointment and preparation method thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN105853560A true CN105853560A (en) | 2016-08-17 |
Family
ID=56641400
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610361744.5A Pending CN105853560A (en) | 2016-05-27 | 2016-05-27 | Pimaricin dermatitis ointment and preparation method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105853560A (en) |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1327832A (en) * | 2001-06-15 | 2001-12-26 | 姜莉蔚 | Exterior-applied ointment for treating dermatitis |
CN1622820A (en) * | 2002-04-15 | 2005-06-01 | 山东哲夫 | Therapeutic cream for dermatitis |
CN1623572A (en) * | 2003-12-05 | 2005-06-08 | 韩播 | Anti-inflammation medicine |
CN1679754A (en) * | 2005-01-20 | 2005-10-12 | 李木林 | Strong-effect external-applied preparation for treating multiple skin diseases |
-
2016
- 2016-05-27 CN CN201610361744.5A patent/CN105853560A/en active Pending
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1327832A (en) * | 2001-06-15 | 2001-12-26 | 姜莉蔚 | Exterior-applied ointment for treating dermatitis |
CN1622820A (en) * | 2002-04-15 | 2005-06-01 | 山东哲夫 | Therapeutic cream for dermatitis |
CN1623572A (en) * | 2003-12-05 | 2005-06-08 | 韩播 | Anti-inflammation medicine |
CN1679754A (en) * | 2005-01-20 | 2005-10-12 | 李木林 | Strong-effect external-applied preparation for treating multiple skin diseases |
Non-Patent Citations (1)
Title |
---|
王宏图 等: "《皮肤科药物手册》", 31 May 2004, 第二军医大学出版社 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN100384337C (en) | Health-caring highland barley tea and its preparing process | |
CN102178809B (en) | Externally-applied medicament for skin and method for processing medicament into preparation | |
KR20090031297A (en) | Method for making pills for obsteric symptoms | |
CN111150828A (en) | Pure Chinese herbal medicine medicated bath formula for health care and health preservation | |
CN105998980A (en) | Anti-virus traditional Chinese medicinal composition and preparation method thereof | |
CN1315457C (en) | Bath lotion for chilblain nursing and preparation method thereof | |
CN101361911A (en) | External skin composition with wrinkle-dispelling function and production method thereof | |
CN102000155A (en) | Medicated wine with effect of promoting blood circulation and removing blood stasis | |
CN104435634A (en) | Medicine for treating white-spot disease caused by aeromonas | |
CN104435686A (en) | Use of traditional Chinese medicine preparation in preparation of medicine for treating skin itch and eczema papulosum | |
CN105963662A (en) | Traditional Chinese medicine composition for curing alopecia and preparation method thereof | |
CN105920183A (en) | Abamectin dermatitis ointment and preparation method thereof | |
CN105232824A (en) | Tea oil composition and preparing method and application thereof | |
CN105456715A (en) | Chinese herbal medicine composition for bathing health | |
CN104524164A (en) | Traditional Chinese medicine preparation for treating pruritus and eczema papulosum and preparation method thereof | |
CN105106524A (en) | Traditional Chinese medicine for treating milk cow mastitis, and preparation method thereof | |
CN105853560A (en) | Pimaricin dermatitis ointment and preparation method thereof | |
CN103989975A (en) | Traditional Chinese medicine preparation for the treatment of hepatitis b | |
CN107411464A (en) | A kind of health care's medicine-filled pillow and preparation method thereof | |
CN105998308A (en) | Nystatin dermatitis ointment and preparation method thereof | |
CN105853561A (en) | Candicidin dermatitis ointment and preparing method thereof | |
CN105878579A (en) | Gibberellin dermatitis ointment and preparation method thereof | |
CN105769628A (en) | Itching relieving liquid shampoo | |
CN103417783A (en) | TCM seaweed mask for treatment of facial steroid corticosteroid dependent dermatitis | |
CN102327440A (en) | Chinese herbal medicine for treating deep multiple abscess |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20160817 |
|
RJ01 | Rejection of invention patent application after publication |